{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:17:27Z","timestamp":1792513047102,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-024-03687-0","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T08:02:46Z","timestamp":1728374566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Two-year outcomes of intravitreal conbercept therapy for polypoidal choroidal vasculopathy"],"prefix":"10.1186","volume":"24","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingli","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gezhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"key":"3687_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.04.002","volume":"53","author":"CW Wong","year":"2016","unstructured":"Wong CW, Yanagi Y, Lee W-K, Ogura Y, Yeo I, Wong TY, et al. Age-related macular degeneration and polypoidal choroidal vasculopathy in asians. Prog Retin Eye Res. 2016;53:107\u201339.","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"3687_CR2","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","volume":"125","author":"CMG Cheung","year":"2018","unstructured":"Cheung CMG, Lai TYY, Ruamviboonsuk P, Chen SJ, Chen Y, Freund KB, et al. Polypoidal Choroidal Vasculopathy: definition, Pathogenesis, diagnosis, and management. Ophthalmology. 2018;125(5):708\u201324.","journal-title":"Ophthalmology"},{"issue":"3","key":"3687_CR3","first-page":"443","volume":"128","author":"CMG Cheung","year":"2021","unstructured":"Cheung CMG, Lai TYY, Teo K, Ruamviboonsuk P, Chen S-J, Kim JE, et al. Polypoidal Choroidal Vasculopathy Ophthalmol. 2021;128(3):443\u201352.","journal-title":"Polypoidal Choroidal Vasculopathy Ophthalmol"},{"issue":"8","key":"3687_CR4","first-page":"1577","volume":"35","author":"CW Wong","year":"2015","unstructured":"Wong CW, Cheung CMG, Mathur R, Li X, Chan CM, Yeo I, et al. Three-year results of polypoidal choroidal vasculopathy treated with photodynamic therapy retrospective study and systematic review. Retina-J Ret Vit Dis. 2015;35(8):1577\u201393.","journal-title":"Retina-J Ret Vit Dis"},{"issue":"11","key":"3687_CR5","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","volume":"135","author":"A Koh","year":"2017","unstructured":"Koh A, Lai TYY, Takahashi K, Wong TY, Chen L-J, Ruamviboonsuk P, et al. Efficacy and safety of Ranibizumab with or without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy. JAMA Ophthalmol. 2017;135(11):1206\u201313.","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"3687_CR6","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1001\/jamaophthalmol.2018.1804","volume":"136","author":"WK Lee","year":"2018","unstructured":"Lee WK, Iida T, Ogura Y, Chen S-J, Wong TY, Mitchell P, et al. Efficacy and safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET study. JAMA Ophthalmol. 2018;136(7):E1\u20138.","journal-title":"JAMA Ophthalmol"},{"issue":"14","key":"3687_CR7","first-page":"37","volume":"10","author":"JZ Ming Zhang","year":"2008","unstructured":"Ming Zhang JZ, Mi Y, Li H, Yang C. Recombinant anti-vascular endothelial growth factor fusion protein efficiently suppresses choridal neovasularization in monkeys. Mol Vis. 2008;10(14):37\u201349.","journal-title":"Mol Vis"},{"issue":"4","key":"3687_CR8","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ophtha.2010.08.008","volume":"118","author":"M Zhang","year":"2011","unstructured":"Zhang M, Zhang J, Yan M, Luo D, Zhu W, Kaiser PK, et al. A phase 1 study of KH902, a vascular endothelial growth factor receptor decoy, for exudative age-related Macular Degeneration. Ophthalmology. 2011;118(4):672\u20138.","journal-title":"Ophthalmology"},{"issue":"6","key":"3687_CR9","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1007\/s00417-020-04988-y","volume":"259","author":"L-H Ye","year":"2020","unstructured":"Ye L-H, Cai Y, Shi X, Wong IYH, Qu J-F, Zhao M-W, et al. One-year results of intravitreal conbercept in treatment-na\u00efve subjects with polypoidal choroidal vasculopathy. Graefe\u2019s Archive Clin Experimental Ophthalmol. 2020;259(6):1455\u201362.","journal-title":"Graefe\u2019s Archive Clin Experimental Ophthalmol"},{"issue":"1","key":"3687_CR10","first-page":"51","volume":"12","author":"E-ZJ Hui-Jun Qi","year":"2019","unstructured":"Hui-Jun Qi E-ZJ, Ming-Wei, Zhao. One-year outcomes of intravitreal conbercept combined rescue therapy for polypoidal choroidal vasculopathy in a Chinese population: a real-life clinical data. Int J Ophthalmol. 2019;12(1):51\u20137.","journal-title":"Int J Ophthalmol"},{"issue":"4","key":"3687_CR11","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/IAE.0b013e3182852446","volume":"33","author":"HC Adrian","year":"2013","unstructured":"Adrian HC, Koh; Expert PCV, Lee-Jen Chen P, Chen S-JCY, Giridhar A, Iida T, Kim H. Timothy Yuk Yau Lai, Won Ki Lee, Xiaoxin Li, Tock Han Lim, Paisan Ruamviboonsuk, Tarun Sharma, Shibo Tang, Mitsuko Yuzawa. Polypoidal choroidal vasculopathy evidence-based guidelines for clinical diagnosis and treatment. Retina. 2013;33(4):686\u2013716.","journal-title":"Retina"},{"issue":"8","key":"3687_CR12","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","volume":"32","author":"WKL Adrian Koh","year":"2012","unstructured":"Adrian Koh WKL, Chen L-J, Chen S-J, Hashad Y, Kim H, Timothy Y, Lai S, Pilz P, Ruamviboonsuk E, Tokaji A, Weisberger, Tock H, Lim. EVEREST STUDY Efficacy and Safety of Verteporfin photodynamic therapy in combination with ranibizumab or alone Versus Ranibizumab Monotherapy in patients with symptomatic Macular Polypoidal Choroidal Vasculopathy. Retina. 2012;32(8):1453\u201364.","journal-title":"Retina"},{"issue":"3","key":"3687_CR13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/IAE.0000000000002430","volume":"40","author":"RS Avi Ohayon","year":"2020","unstructured":"Avi Ohayon RS, Semoun O, Corbelli E, Souied EH, Querques G, Choroidal neovascular area and vessel density comparison between two swept-source optical coherence tomography angiography devices. Retina. 2020;40(3):521\u20138.","journal-title":"Retina"},{"key":"3687_CR14","doi-asserted-by":"publisher","first-page":"101057","DOI":"10.1016\/j.ajoc.2021.101057","volume":"22","author":"M Shen","year":"2021","unstructured":"Shen M, Bo Q, Song M, Jiang X, Yehoshua Z, Gregori G, et al. Replacement of polyps with type 1 macular neovascularization in polypoidal choroidal vasculopathy imaged with swept source OCT angiography. Am J Ophthalmol Case Rep. 2021;22:101057.","journal-title":"Am J Ophthalmol Case Rep"},{"key":"3687_CR15","first-page":"339","volume-title":"Short-term efficacy of intravitreal conbercept in treatment-naive patients with polypoidal choroidal vasculopathy","author":"Y Peng","year":"2018","unstructured":"Peng Y, Zhang X, Li M, Liu B, Mi L, Zuo C, et al. Short-term efficacy of intravitreal conbercept in treatment-naive patients with polypoidal choroidal vasculopathy. Volume 12. Development and Therapy: Drug Design; 2018. pp. 339\u201345."},{"issue":"2","key":"3687_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00417-014-2688-1","volume":"253","author":"M Hata","year":"2014","unstructured":"Hata M, Tsujikawa A, Miyake M, Yamashiro K, Ooto S, Oishi A, et al. Two-year visual outcome of ranibizumab in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Graefe\u2019s Archive Clin Experimental Ophthalmol. 2014;253(2):221\u20137.","journal-title":"Graefe\u2019s Archive Clin Experimental Ophthalmol"},{"issue":"10","key":"3687_CR17","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1097\/IAE.0000000000001818","volume":"38","author":"SS Maiko Maruyama-Inoue","year":"2018","unstructured":"Maiko Maruyama-Inoue SS, Shin, Yamane. Kazuaki Kadonosono. Intravitreal injection of aflibercept in patients with polypoidal choroidal vasculopathy a 3-year follow-up. Retina. 2018;38(10):2001\u20139.","journal-title":"Retina"},{"issue":"21","key":"3687_CR18","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.4103\/0366-6999.192779","volume":"129","author":"XS Yong Cheng","year":"2016","unstructured":"Yong Cheng XS, Qu J-F, Zhao M-W, Li X-X. Comparison of the 1\u2013year outcomes of Conbercept Therapy between two different angiographic subtypes of Polypoidal Choroidal Vasculopathy. Chin Med J. 2016;129(21):2610\u20136.","journal-title":"Chin Med J"},{"issue":"9","key":"3687_CR19","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/eye.2013.179","volume":"27","author":"M Inoue","year":"2013","unstructured":"Inoue M, Arakawa A, Yamane S, Kadonosono K. Long-term outcome of intravitreal ranibizumab treatment, compared with photodynamic therapy, in patients with polypoidal choroidal vasculopathy. Eye. 2013;27(9):1013\u20132120.","journal-title":"Eye"},{"key":"3687_CR20","doi-asserted-by":"crossref","unstructured":"Bo Q, Zhang M, Chen J, Jia H, Shen M, Sun M et al. Progression of Polypoidal Lesions Associated with Exudative recurrence in Polypoidal Choroidal Vasculopathy. Ophthalmology. 2022.","DOI":"10.1016\/j.ophtha.2022.09.013"},{"issue":"8","key":"3687_CR21","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1136\/bjophthalmol-2019-315189","volume":"104","author":"R Forte","year":"2020","unstructured":"Forte R, Coscas F, Serra R, Cabral D, Colantuono D, Souied EH. Long-term follow-up of quiescent choroidal neovascularisation associated with age-related macular degeneration or pachychoroid disease. Br J Ophthalmol. 2020;104(8):1057\u201363.","journal-title":"Br J Ophthalmol"},{"key":"3687_CR22","doi-asserted-by":"crossref","unstructured":"Vavvas DG, Coscas F, Cabral D, Pereira T, Geraldes C, Narotamo H et al. Quantitative optical coherence tomography angiography biomarkers for neovascular age-related macular degeneration in remission. PLoS ONE. 2018;13(10).","DOI":"10.1371\/journal.pone.0205513"},{"issue":"2","key":"3687_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41433-021-01688-7","volume":"36","author":"BJ Fenner","year":"2021","unstructured":"Fenner BJ, Cheung CMG, Sim SS, Lee WK, Staurenghi G, Lai TYY, et al. Evolving treatment paradigms for PCV. Eye. 2021;36(2):257\u201365.","journal-title":"Eye"},{"issue":"10","key":"3687_CR24","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1167\/iovs.18-26478","volume":"60","author":"A Au","year":"2019","unstructured":"Au A, Hou K, D\u00e1vila JP, Gunnemann F, Fragiotta S, Arya M, et al. Volumetric analysis of Vascularized Serous Pigment Epithelial detachment progression in Neovascular Age-Related Macular Degeneration using Optical Coherence Tomography Angiography. Invest Opthalmology Visual Sci. 2019;60(10):3310\u20139.","journal-title":"Invest Opthalmology Visual Sci"},{"issue":"7","key":"3687_CR25","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1097\/IAE.0000000000000130","volume":"34","author":"KBF Ehsan Rahimy","year":"2014","unstructured":"Ehsan Rahimy KBF, Larsen M, Spaide RF, Costa RA, Hoang Q, Christakopoulos C, Inger C, Munch. David Sarraf. Multilayered pigment epithelial detachment in neovascular agerelated macular degeneration. Retina. 2014;34(7):1289\u201395.","journal-title":"Retina"},{"issue":"1","key":"3687_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00417-003-0828-0","volume":"242","author":"RO Schlingemann","year":"2003","unstructured":"Schlingemann RO. Role of growth factors and the wound healing response in age-related macular degeneration. Graefe\u2019s Archive Clin Experimental Ophthalmol. 2003;242(1):91\u2013101.","journal-title":"Graefe\u2019s Archive Clin Experimental Ophthalmol"},{"issue":"12","key":"3687_CR27","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1038\/eye.2017.126","volume":"31","author":"JH Kim","year":"2017","unstructured":"Kim JH, Chang YS, Kim JW, Kim CG, Lee DW. Submacular hemorrhage and grape-like polyp clusters: factors associated with reactivation of the lesion in polypoidal choroidal vasculopathy. Eye. 2017;31(12):1678\u201384.","journal-title":"Eye"},{"issue":"3","key":"3687_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00417-017-3877-5","volume":"256","author":"JH Kim","year":"2018","unstructured":"Kim JH, Chang YS, Kim CG, Lee DW, Han JI. Hyperpigmented spots after treatment for submacular hemorrhage secondary to polypoidal choroidal vasculopathy. Graefe\u2019s Archive Clin Experimental Ophthalmol. 2018;256(3):469\u201377.","journal-title":"Graefe\u2019s Archive Clin Experimental Ophthalmol"},{"issue":"10","key":"3687_CR29","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1097\/IAE.0000000000001817","volume":"38","author":"JHK Jiwon Baek","year":"2018","unstructured":"Jiwon Baek JHK, Lee MY, Lee WK, Disease activity after development of large subretinal hemorrhage in polypoidal choroidal vasculopathy. Retina. 2018;38(10):1993\u20132000.","journal-title":"Retina"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03687-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-024-03687-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03687-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T20:17:35Z","timestamp":1728418655000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-024-03687-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3687"],"URL":"https:\/\/doi.org\/10.1186\/s12886-024-03687-0","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,8]]},"assertion":[{"value":"5 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was established, according to the ethical guidelines of the Helsinki Declaration and was approved by the Institutional Review Board of Eye and ENT Hospital of Fudan University. Written informed consent was obtained from individual participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"441"}}